StockGlow

CNBX Pharmaceuticals Inc. (CNBX)

Develops cannabinoid-based drugs to treat cancer and related conditions.

$0.00+0.00%Healthcare
Compare CNBX with
StockGlow Score
6
Bearish
BearishBullish
1 year ago-80.0%

The outlook

CNBX trades at $0.0001, well below both its 50- and 200-day moving averages and sitting near its 52-week low. Analyst coverage appears minimal or unavailable. The overall sentiment leans bearish based on current technical positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Market cap
$160,576
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

AMMJAmerican Cannabis Company, Inc.$0.00+0.00%OWCPOWC Pharmaceutical Research Corp.$0.00+0.00%DOGPDogecoin Cash, Inc.$0.01+7.79%AXIMAXIM Biotechnologies, Inc.$0.00-9.09%CANNTrees Corporation$0.02-17.96%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy